Home/Neuropeutics/Marc Shenouda, PhD
MS

Marc Shenouda, PhD

CEO & Co-Founder

Neuropeutics

Neuropeutics Pipeline

DrugIndicationPhase
JRMS-22Amyotrophic Lateral Sclerosis (ALS)Preclinical